Australia - English - Department of Health (Therapeutic Goods Administration)

shen neng herbal medicines group pty ltd - viola yedoensis, quantity: 303 mg (equivalent: viola yedoensis, qty 818.1 mg); taraxacum mongolicum, quantity: 303 mg (equivalent: taraxacum mongolicum, qty 818.1 mg); isatis tinctoria, quantity: 303 mg (equivalent: isatis tinctoria, qty 818.1 mg) - tablet, sugar coated - excipient ingredients: - traditionally used in chinese medicine to remove heat toxin ; traditionally used in chinese medicine to anti-inflammatory/relieve inflammation ; traditionally used in chinese medicine to decrease/reduce/relieve symptoms of common colds and flu ; traditionally used in chinese medicine to decrease/reduce/relieve symptoms of mild tonsillitis

Israel - English - Ministry of Health

cts ltd - ulipristal acetate - tablets - ulipristal acetate 30 mg - ulipristal - ulipristal - emergency contraception within 120 hours (5 days) of unprotected sexual intercourse or contraceptive failure.

Israel - English - Ministry of Health

novartis israel ltd - nilotinib as monohydrate - capsules - nilotinib as monohydrate 200 mg - nilotinib - nilotinib - treatment of philadelphia chromosome positive chronic myeloid leukaemia (ph+ cml) in chronic or accelerated phase in patients resistant to or experiencing significant toxicity during treatment with imatinib.treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

Israel - English - Ministry of Health

novartis israel ltd - nilotinib as hydrochloride monohydrate - capsules - nilotinib as hydrochloride monohydrate 150 mg - nilotinib - nilotinib - treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myelogenous leukemia in chronic phase.

Israel - English - Ministry of Health

j-c health care ltd - topiramate - film coated tablets - topiramate 25 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topamax is indicated in adults for the prevention of migraines. the use of topamax in the acute treatment of migraine has not been studied.

Israel - English - Ministry of Health

j-c health care ltd - topiramate - film coated tablets - topiramate 50 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topamax is indicated in adults for the prevention of migraines. the use of topamax in the acute treatment of migraine has not been studied.

Israel - English - Ministry of Health

j-c health care ltd - topiramate - film coated tablets - topiramate 100 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topamax is indicated in adults for the prevention of migraines. the use of topamax in the acute treatment of migraine has not been studied.

Israel - English - Ministry of Health

j-c health care ltd - topiramate - film coated tablets - topiramate 200 mg - topiramate - topiramate - in adjunctive therapy of adults and children (from 2 years) with partial seizures and generalized tonic-clonic seizures. in adjunctive therapy of seizures with lennox-gastaut syndrome in adults and children. topamax is indicated as monotherapy in patients with newly diagnosed epilepsy in children aged 7 years and above or for conversion to monotherapy in patients with epilepsy. topamax is indicated in adults for the prevention of migraines. the use of topamax in the acute treatment of migraine has not been studied.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dafra pharma gmbh - amoxicillin 200mg,clavulanic acid 28mg - dafraclav® is indicated in the treatment of the following in­fections caused by the microorganisms indicated below. upper respiratory tract infections (including otitis media and sinusitis), due to beta-lactamase producing strains of haemophilus influenzae and moraxella catarrhalis. lower respiratory tract infections, due to beta-lactamase producing strains of haemophilus influenzae and moraxella catarrhalis. skin and skin structure infections, due to beta-lactamase producing strains of staphylococcus aureus, escherichia coli and klebsiella spp. urinary tract infections. since dafraclav® contains amoxicillin, it can be used in the treatment of infections caused by bacteria susceptible to ampicillin. additionally, if in a mixed infection a microorganisms is susceptible to ampicillin and the other which is a beta-lactamase producer is susceptible to dafraclav®, such an infection can be treated by the administration of dafraclav® alone, addition of another antibiotic is not required.

Nigeria - English - NAFDAC (National Agency for Food and Drugs Administration and Control)

dafra pharma gmbh - amoxicillin + clavulanic acid - amoxicillin 400mg,clavulanic acid 57mg - dafraclav is indicated in the treatment of the following infections caused by the microorganisms indicated below. - upper respiratory tract infections (including otitis media and sinusitis), due to beta-lactamase producing strains of haemophilus influenzae and moraxella catarrhalis. - lower respiratory tract infections, due to beta-lactamase producing strains of haemophilus influenzae and moraxella catarrhalis. - skin and skin structure infections, due to beta-lactamase producing strains of staphylococcus aureus, escherichia coli and klebsiella spp. - urinary tract infections. since dafraclav contains amoxicillin, it can be used in the treatment of infections caused by bacteria susceptible to ampicillin. additionally, if in a mixed infection a microorganisms is susceptible to ampicillin and the other which is a beta-lactamase producer is susceptible to dafraclav, such an infection can be treated by the administration of dafraclav alone, addition of another antibiotic is not required.